Home / Health / Estrogen Loss Linked to Alzheimer's Risk
Estrogen Loss Linked to Alzheimer's Risk
2 Jun
Summary
- Female brains may be sensitive to estrogen loss during menopause.
- Estrogen decline affects the brain's extracellular matrix, impacting memory.
- More research is needed to confirm hormone therapy's role in preventing dementia.
New research indicates that women's brains may be particularly vulnerable to the decline in estrogen experienced during menopause, suggesting a potential link to the higher prevalence of Alzheimer's disease in women. This preclinical study, conducted on mice, found that estrogen loss, aging, and being female were associated with issues in the extracellular matrix (ECM).
The ECM is a vital network filling spaces between brain cells, supporting memory, development, and brain health. Researchers propose that estrogen loss may dysregulate the ECM, impacting the hippocampus, a region critical for memory consolidation, and potentially increasing Alzheimer's-related memory deficits.
While men also experience reduced estrogen production with age, women's brains appear to rely more heavily on its protective effects for memory and mood regulation. Experts note that menopausal brain fog, often temporary, differs from the persistent cognitive decline linked to a higher risk of dementia.
The potential benefits of hormone replacement therapy (HRT) for cognitive decline are still under investigation. While some studies suggest positive effects on memory, robust clinical trials are needed to confirm efficacy and safety for Alzheimer's prevention. Doctors advise discussing HRT with a healthcare provider, considering that benefits may outweigh risks for younger postmenopausal women.
